39 peer-reviewed studies · Evidence score: 7.5/10
Vårvik FT et al. • International Journal of Sport Nutrition and Exercise Metabolism (2021)
Supplementing with 6-8g CitMal increased repetitions by 6.4% compared with placebo.
Rhim HC et al. • Journal of Sport and Health Science (2020)
Citrulline supplementation significantly reduced RPE and muscle soreness 24-48h post-exercise.
Trexler ET et al. • Journal of the International Society of Sports Nutrition (2019)
Small effect size of 0.20 for strength and power outcomes.
Aguiar AF et al. • Journal of dietary supplements (2022)
Accordingly, our findings suggest that citrulline malate supplementation does not improve muscle strength in healthy and resistance-trained individuals (PROSPERO registration number: CRD42020159338).
Gonzalez AM et al. • Journal of strength and conditioning research (2020)
Given the positive effects observed from some investigations, future studies should continue to investigate the effects of both acute and chronic supplementation with L-citrulline and citrulline malate on markers of blood flow and exercise performance and should seek to elucidate the mechanism underlying such effects.
Devrim-Lanpir A et al. • Nutrients (2024)
This study highlights the need for further research with larger sample sizes, both genders, and different CM dosages to clarify these findings and better understand CM's role in enhancing athletic performance.
Martín-Olmedo JJ et al. • International journal of sport nutrition and exercise metabolism (2025)
This trial was registered at ClinicalTrials.gov (No. NCT05183893).
Ramírez-Munera M et al. • Nutrients (2025)
These effects could reflect improved tolerance to high training loads and sustained NO3- availability during recovery.
Bürkle F et al. • Journal of the International Society of Sports Nutrition (2022)
Based on our novel examination protocol, CEUS seems to be feasible following higher-load resistance exercising and may be used as a new method for high-resolution perfusion quantification to investigate the effects of pre-exercise dietary supplementation on muscle perfusion and related muscle size dynamics.
Bezuglov E et al. • Nutrients (2022)
Neither a single intake of 3 g nor of 6 g of citrulline malate affected physical performance, subjective feelings of fatigue or post-exercise recovery in adult elite soccer players who performed a soccer-specific test.
Selvaraj S et al. • Scientific reports (2025)
This rct examined the effects of Citrulline Malate.
Faria VS et al. • European journal of sport science (2024)
European Journal of Sport Science
Tinsley GM et al. • Journal of the International Society of Sports Nutrition (2017)
As compared to placebo, caffeinated and non-caffeinated multi-ingredient pre-workout supplements failed to improve concentric and eccentric force production.
Domingues V et al. • Journal of dietary supplements (2024)
The study found no significant changes in the post-exercise nocturnal blood pressure dip following a single dose of CM supplementation.
Gills JL et al. • Journal of strength and conditioning research (2023)
Additional research is needed to identify timing efficacy of CM to increase sport performance during each phase of the menstrual cycle.
Schwarz NA , PhD et al. • Journal of dietary supplements (2020)
No differences in human growth hormone (HGH) or serum cortisol responses were observed between trials.
Kruszewski M et al. • Nutrients (2022)
These results indicate that MIPS supplementation is less ergogenic and cost effective than caffeine alone.
Gills JL et al. • European journal of sport science (2021)
Conclusion: Acute CM supplementation in recreationally active males provides no ergogenic benefit in aerobic cycling performance followed by an anaerobic cycling test.
Douligeris A et al. • Nutrients (2023)
Thus, although players' alactic and lactic anaerobic performance could be improved, peak power, sprinting and aerobic performance are not.
Rogers JM et al. • Journal of the International Society of Sports Nutrition (2020)
Nitrosigine (23%) and CM (25%) generated significantly greater allometric scaled FMD values when compared to the placebo trial (0.60%).